Fibronectin (FN) is a major extracellular matrix protein implicated in cell adhesion and differentiation in the bone marrow (BM) environment. Alternative splicing of FN gene results in the generation of protein variants containing an additional EIIIA domain that sustains cell proliferation or differentiation during physiological or pathological tissue remodeling. To date its expression and role in adult hematopoiesis has not been explored. In our research, we demonstrate that during physiological hematopoiesis a small fraction of BM derived FN contains the EIIIA domain and that mice constitutively including (EIIIA 1/1 ) or excluding (EIIIA 2/2 ) the EIIIA exon present comparable levels of hematopoietic stem cells, myeloid and lymphoid progenitors within BM. Moreover, only minor alterations were detected in blood parameters and in hematopoietic frequencies of BM granulocytes/monocytes and B cells. As opposed to other tissues, unique compensatory mechanisms, such as increased FN accumulation and variable expression of the EIIIA receptors, Toll like receptor-4 and alpha9 integrin subunit, characterized the BM of these mice. Our data demonstrate that FN is a fundamental component of the hematopoietic tissue and that the EIIIA exon may play a key role in modulating hematopiesis in conditions of BM stress or diseases. STEM CELLS 2016;34:2263-2268 
INTRODUCTION
Fibronectin (FN) is an extracellular matrix (ECM) glycoprotein that plays a regulatory role during embryogenesis, wound healing and maintenance of tissue integrity [1] . The FN1 gene encodes 15 type III repeats that are constitutively expressed plus 2 that are alternatively spliced: extra domain A (EIIIA, ED-A) and extra domain B (EIIIB, ED-B) [2] . EIIIA exon is included or excluded from the FN mRNA by exon skipping [3, 4] . Plasma FN lacks both EIIIA and EIIIB segments and is a soluble form secreted by hepatocytes, whereas cellular FN contains variable proportions of EIIIA and EIIIB segments and is found as fibrils in the ECM [5] . Increased expression of the EIIIA 1 and EIIIB 1 isoforms of FN are associated with physiological or pathological tissue remodeling, including wound healing [6] , tissue fibrosis [7] , fibroblast differentiation [8] , inflammation [9] and tumor progression [10] .
Blood cell formation is controlled by a complex set of events, including interactions between ECM components and hematopoietic cells. Within bone marrow (BM) environment, FN represents a major ECM component supposed to play important roles in various aspects of hematopoiesis through binding to very late antigen 4 (VLA4) and 5 (VLA5) [11] . However, effects of FN variants on hematopoietic stem cell behavior are largely unknown. In particular, the expression and precise localization of FN variants within BM environment could be instrumental for a fine control of the interactions between cells with resulting changes in cell adhesion, migration, and growth [12, 13] ]. In the present work we studied the role of EIIIA FN isoform in murine hematopoiesis taking advantage of two mouse strains unable to undergo a regular alternative splicing of the EIIIA exon. One strain contains optimized spliced sites at both splicing junctions of the EIIIA exon and constitutively includes the exon (EIIIA 1/1 ), whereas the other strain contains an EIIIAnull allele of the EIIIA exon (EIIIA 2/2 ) [6] .
MATERIALS AND METHODS
Animals C57BL/6 wild type mice were from Charles River Laboratories, Italy. EIIIA 1/1 and EIIIA 2/2 mouse strains were previously generated [6] . Six to eight weeks old mice were used in all experiments. Mice were housed at the animal facility of the Department of Physiology, section of General Physiology, University of Pavia (approval # 3/2013, 19/11/2013). All animals were sacrificed according to the current European legal Animal Practice requirements.
Antibodies and Reagents
The following antibodies were used: anti rat FN was from Chemicon (Merck-Millipore, Milan, Italy), anti cellular FN 3E2, anti laminin and anti b-actin antibodies were from Sigma Aldrich. Anti mouse integrin alpha9 and anti type I collagen were from Abcam (Cambridge, U.K.). Anti TLR4 (clone 25) was from Santa Cruz Biotechnology Inc. Human plasma FN was purchased from BD Bioscience (Milan, Italy), cellular FN from human skin fibroblasts was from Sigma-Aldrich (Milan, Italy).
Statistics
Values are expressed as mean 6 SD. One way ANOVA and two way ANOVA followed by a Bonferroni post-test were used to analyze experiments. p value statistically significant were expressed as *, p < .05, **, p < .01, and ***, p < .001 respectively.
Extended information on experimental procedures are available in Supporting Information.
RESULTS AND DISCUSSION
To decipher the role of the FN EIIIA domain in the biology of the hematopoietic system, we first evaluated its expression in the BM matrix of adult mice. As shown in Fig. 1A , deoxycholic acid (DOC) insoluble fibrillar proteins derived from BM were analyzed by western blotting and FN was detected by a polyclonal antibody that recognizes both plasmatic and cellular isoforms (left panel). Importantly, a small fraction of this fibrillar FN stained positive also for a monoclonal antibody directed against the EIIIA domain (right panel). We further performed a detailed analysis of cellular EIIIA-FN mRNA expression. As demonstrated in Fig. 1B higher levels of EIIIA FN expression were detected in sorted CD45-/CD31 1 endothelial cells and CD45-/ CD31-/PDGFRa?CD140a? 1 stromal cells with respect to hematopoietic mononuclear CD45 1 cells.
To measure the effects of the EIIIA domain in the hematopoietic system, we analyzed mouse strains unable to undergo alternative splicing of the FN EIIIA exon. As shown in Fig. 1C -1E, EIIIA 1/1 and EIIIA 2/2 displayed opposite levels of spliced EIIIA exon at mRNA level, comparable levels in the splicing rate of IIICS region, while, inclusion of EIIIB domain was not detected in the adult hematopoietic tissue. These results confirmed the autonomy of the alternatively spliced regions of the FN1 gene in the transgenic EIIIA mice and confirmed the absence of EIIIB domain in the FN of the hematopoietic tissue, as previously described in other tissues during mice development and aging [14] .
Both mouse strains presented regular BM cell count ( Fig.  1F-1G ) and regular FN assembly in the BM extracellular matrix (Fig. 1G ). Frequencies and absolute number of KSL stem cells were comparable in all mice strains, as well as myeloid and lymphoid progenitors, suggesting that the splicing of EIIIA exon is dispensable for adult KSL self-renewal and differentiation ( Fig. 2A-2G ). We then analyzed the frequencies of mature blood cell lineages in the peripheral blood (PB) by differential cell count analysis. Interfering with FN splicing of EIIIA exon did not determine a significant alteration of most of the blood parameters in the PB of EIIIA 1/1 and EIIIA 2/2 mouse models. As reported in Supporting Information Table  1 , we only observed a significant difference in the mean platelet volume (MPV) that resulted significantly higher in EIIIA 1/ 1 mice. In order to better characterized the hematopoietic system of these mice, we then analyzed the immunophenotype of the cell population of the BM, the spleen and the PB by flow cytometry. As shown in Fig. 3A, 3C , EIIIA 1/1 mice dis-played a reduction in the percentage of B220 1 B cells with respect to wild type and EIIIA 2/2 mice (mean 35.52 vs. 26.43 vs. 32.33%) (p < .001 and .05, respectively). Differently, BM cells in the EIIIA 2/2 mice were characterized by an increase in granulocyte/monocyte content as revealed by Gr-1/Mac-1 staining of cells by flow cytometry (FACS) (mean EIIIA wt/wt 34.57 vs. EIIIA 1/1 39.11 vs. EIIIA 2/2 45.02%, p < .05). No significant alterations in BM T lymphocyte and macrophage content were detected. Importantly, these slight modifications in cell frequencies were specifically found in the BM although no significant differences in structure, FN deposition and cell lineage frequencies were detected in the spleen or PB of both mice models (Fig. 3B , 3D-E; Supporting Information Fig.  S1A ). The reduction in total B-cells within BM in EIIIA 1/1 led us to characterize B cell maturation by analyzing the subsequent stages of B-cell development. As shown in Supporting Information Fig. S1B -E, we did not identify blocks in B-cell development in EIIIA 1/1 mice, but only a reduction of Pre B and Pro B cell progenitors within BM (p < .05). Furthermore, the frequencies of marginal and transitional T1 B cells in the spleen, mature and transitional T2 cells of spleen and PB in both mouse models were comparable to those of wild type (Supporting Information Fig. S1 ). Overall, when we calculated the ratio between the frequency of the B cell subpopulation and the absolute number of the BM mononuclear cells, we did not observe significant differences (data not shown). Taken together these data proved that the hematopoietic tissue was comparable, in terms of cell composition, in all the three different genotypes we analyzed.
Genetic manipulation of FN1 gene in the EIIIA 1/1 mice was demonstrated to induce a striking decrease in FN levels in most tissues of the body [6] . Interestingly, the hematopoietic tissue was not affected by a reduction in FN amount, highlighting the importance of FN in the regulation of hematopoietic tissue homeostasis. As shown in Fig. 4A, 4B , FN protein level was increased in BM-derived MNCs from EIIIA 1/1 mice, whereas comparable levels of FN were present in spleen-derived MNCs among all mice genotypes.
The increase in BM content of FN in the EIIIA 1/1 mice did not seem to be a consequence of increased gene expression, as a comparable expression of the FN1 gene was detected in BM cells derived from all mice (Fig. 4C ). Therefore this increase in FN protein in the EIIIA 1/1 mice might derive from mechanisms of extravasation or uptake of plasmaderived FN that was previously shown to constitute an additional source of tissue FN in several organs [5] . In support of this statement, deposition of other ECMs, such as type I collagen or laminin, in the BM was unaffected by FN gene manipulation (Supporting Information Fig. S2) .
The EIIIA segment of FN has been showed to contain binding sites for leukocyte integrins a9b1, a4b1, and a4b7, providing a novel mechanism for regulating cell adhesion by alternative splicing [15] . Additionally, EIIIA domain was recently demonstrated to activate the Toll Like Receptor 4 (TLR4), involved in the defense in the innate immune response following recognition of pathogens associated molecular patterns [16] . Interestingly, the signaling associated with these receptors has been implicated in the direction of granulopoiesis and stem cell differentiation during the immune response [17] , [18] . Analysis of EIIIA receptor expression in our mice, revealed that the higher amount of cellular EIIIA FN in the BM of EIIIA 1/1 mice was accompanied by an increased expression of both TLR4 and alpha9 integrin subunit ( Fig. 4D-4E ) in BM-derived MNCs, but not in spleen-derived MNCs which were exposed to regular amount of tissue FN ( Fig. 4D-4F) . Similarly, only adhesion to cellular FN (containing the EIIIA domain) and not plasma FN (lacking the EIIIA domain) modulated TLR4, and to a lesser extent, alpha9 integrin expression in BM-derived MNCs (Fig. 4G ). Overall, we may hypothesize a model in which the production of FN EIIIA by stromal/endothelial cells can induce the upregulation of its receptors on BM MNCs. Further studies are required to define if the balanced expression of EIIIA FN and its receptors within BM are required to avoid aberrant effects of forced EIIIA domain inclusion into the EIIIA 1/1 mice or necessary to regulate unknown EIIIA-dependent BM processes.
In conclusion, we have documented, for the first time, the effects of FN splicing variants on physiological hematopoiesis by showing how alternatively spliced FNs are implicated in the BM environment homeostasis while deletion or forced inclusion of the EIIIA exon of FN resulted only in minor changes in physiological hematopoiesis. Notably, as opposed to other tissues, unique compensatory mechanisms occurred in the BM to maintain high levels of FN and its receptors in mice constitutively expressing cellular EIIIA FN. These data suggest that alternative splicing of FN may play an important role in maintaining the steady state of the hematopoietic tissue. Alternative spliced EIIIA and EIIIB isoforms of FN have been demonstrated to play a key role in physiological tissue repair [6, 19, 20] , thus further experiments are required to clarify the role of spliced FNs in conditions of hematopoietic stress or hematological malignancies.
